This NCCN-developed webinar presents a great opportunity for clinicians to learn about the latest therapeutic advances in chronic lymphocytic leukemia (CLL). During the live event, the faculty will give a snapshot overview of advances in CLL including risk assessment, molecular profiling, along with current and emerging therapeutics. This overview will be followed by panel discussions of various patient case scenarios with expert recommendations and supporting clinical data. Ongoing clinical trials and promising agents and combinations currently under investigation will also be discussed. A moderated panel discussion and an audience question and answer session will close each section of the symposium and will provide further perspectives on how the experts interpret the available clinical data and apply them in their practice. Participants will be able to fully interact and contribute to the cases discussed by the panel via the virtual platform. Throughout the webinar, participants will have the opportunity to directly query the faculty for further clarification of the education or to obtain expert perspective on their own treatment challenges. The webinar will also feature review and presentation of the latest updates to the NCCN guideline treatment algorithms to help guide practical application.